Fighter's Competition Clearance Panel 1
- $250.95
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: CBC, CBC includes Differential and Platelets, CBC/PLT w/DIFF, Complete Blood Count (includes Differential and Platelets)
NOTE: Ulta Lab Tests provides CBC test results from Quest Diagnostics as they are reported. Often, different biomarker results are made available at different time intervals. When reporting the results, Ulta Lab Tests denotes those biomarkers not yet reported as 'pending' for every biomarker the test might report. Only biomarkers Quest Diagnostics observes are incorporated and represented in the final CBC test results provided by Ulta Lab Tests.
Absolute Band Neutrophils
Absolute Basophils
Absolute Blasts
Absolute Eosinophils
Absolute Lymphocytes
Absolute Metamyelocytes
Absolute Monocytes
Absolute Myelocytes
Absolute Neutrophils
Absolute Nucleated Rbc
Absolute Promyelocytes
Band Neutrophils
Basophils
Blasts
Eosinophils
Hematocrit
Hemoglobin
Lymphocytes
MCH
MCHC
MCV
Metamyelocytes
Monocytes
MPV
Myelocytes
Neutrophils
Nucleated Rbc
Platelet Count
Promyelocytes
RDW
Reactive Lymphocytes
Red Blood Cell Count
White Blood Cell Count
Also known as: Australian Antigen, Auszyme, HBsAg
Confirmation
Hepatitis B Surface
Also known as: Anti HCV, HCV Antibody
Hepatitis C Antibody
Signal To Cut-Off
The Fighter's Competition Clearance Panel 1 panel contains 3 tests with 37 biomarkers .
The Fighter's Competition Clearance Panel contains the following tests:
- Complete Blood Count (CBC) with Differential and Platelets
- Hepatitis B Surface Antigen (HBsAg) with Reflex Confirmation
- Hepatitis C Antibody with Reflex
IMPORTANT: NOTE THIS IS A REFLEX TEST - The price charged for this test is only for the Hepatitis B Surface Antigen. AN ADDITIONAL CHARGE WILL OCCUR FOR THE REFLEX CONFIRMATION if the Hepatitis B Surface Antigen is positive.
The Hepatitis B test detects acute hepatitis B infections, and can also be used to help diagnose chronic hepatitis B infections. Detecting an early hepatitis B infection is important to avoid health complications. If the HBV test positive returns a positive result for hepatitis B, our labs will automatically run a confirmation test at no additional cost– This ensures that you receive the most sensitive and accurate results.
Hepatitis B Surface Antigen with Reflex Confirmation: Positive samples will be confirmed
Hepatitis B surface antigen (HBsAG) Detects protein that is present on the surface of the virus. It is used to screen for, detect, and help diagnose acute and chronic hepatitis B virus (HBV) infections; earliest routine indicator of acute hepatitis B and frequently identifies infected people before symptoms appear; undetectable in the blood during the recovery period; it is the primary way of identifying those with chronic infections, including "hepatitis B virus (HBV) carrier" state.
Clinical Significance
Surface antigen usually appears in the serum after an incubation period of 1 to 6 months following exposure to Hepatitis B virus and peaks shortly after the onset of symptoms. It typically disappears within 1 to 3 months. Persistence of Hepatitis B surface antigen for greater than 6 months is a prognostic indicator of chronic Hepatitis B infection.
Hepatitis C Antibody with Reflex to HCV, RNA, Quantitative, Real-Time PCR
IMPORTANT: If Hepatitis C Antibody is reactive, then the Hepatitis C Viral RNA, Quantitative, Real-Time PCR test will be performed at an additional charge of $129.00.
Limitations
Results obtained from immunosuppressed patients should be interpreted with caution. Patients receiving mouse antibody therapy may produce false-negative results.
Reference Range(s)
Hepatitis C Antibody Non-Reactive
Signal to Cut-off<1.00
Clinical Significance
Hepatitis C Virus (HCV) is a major cause of hepatitis. The clinical symptoms of an HCV infection are variable—infection with HCV results in a chronic infection in 50 to 80% of cases. The "window" between HCV acquisition and seroreactivity is highly variable, up to six months.